Composition
US9220769B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 21, 2012 |
| Grant date | Dec 29, 2015 |
| Priority date | — |
| Expiry date | Sep 21, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16162
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a modified influenza virus wherein the RNA of the haemagglutinin gene has been modified such that the haemagglutinin signal sequence is not expressed and the virus produces a haemagglutinin protein that lacks a functional signal sequence. The invention further provides composition comprising the modified virus and uses of the modified virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.